Skip to main content
. 2017 Sep 8;8(44):77752–77760. doi: 10.18632/oncotarget.20776

Table 2. Summary of meta-analysis results.

N Model Pooled OR (95% CI) P value Heterogeneity (I2, P) Conclusion Publication bias
PFO at 3 months
Total 3 random 2.74 (1.33-5.65) 0.006 60.0%, 0.082 positive 1.000
China 2 fixed 2.11 (1.30-3.43) 0.002 20.1%, 0.263 positive
Italy 1 6.37 (2.33-17.40) positive
Onset to admission ≤ 24h 2 random 3.71 (1.57-8.75) 0.003 55.4%, 0.135 positive
Onset to admission ≤ 7d 1 1.46 (0.65-3.28) negative
Sample time-on admission 2 random 3.71 (1.57-8.75) 0.003 55.4%, 0.135 positive
Sample time-on 2ed morning 1 1.46 (0.65-3.28) negative
Death at 3 months
Total 3 random 1.58 (0.44-5.68) 0.486 93.3%, <0.001 negative 1.000
China 2 random 2.02 (0.27-15.25) 0.496 85.0%, 0.010 negative
Germany 1 0.97 (0.95-1.00) negative
Sample time-on admission 2 random 2.17 (0.43-10.97) 0.350 96.6%, <0.001 negative
Sample time-on 2ed morning 1 0.64 (0.15-2.76) negative

PFO: poor functional outcome, N: number of included studies, OR: odds ratio, CI: confidence interval.